Taking Control
Master the Basics
Think of epilepsy as an ongoing challenge that can be managed.
The way you choose
to deal with your condition, your treatment, any side effects you may experience, and even
your day-to-day routine can have a tremendous impact on the way you live your life. Developing the
right skills now can make a critical difference.
Begin with the basics. There are many things you can do to increase your independence—but there
are a few things you must do.
- Follow your healthcare professional’s instructions. Take your medicine exactly as prescribed,
and consult your healthcare professional before making any changes.
- Stick to your treatment plan. Make taking your medicine a part of your daily routine.
- Take sensible precautions. Speak with your healthcare professional or other healthcare professional
before taking part in activities such as skiing, skateboarding, or scuba diving.
- Avoid alcohol. Alcohol can lower the threshold at which seizures occur and may increase the side
effects of your medicine.
- Minimize stress. Get enough sleep on a regular basis, and avoid unnecessary stress.
- Communicate. Talk with your healthcare professional and those who care about you to let them know
what you’re thinking, how you’re feeling, and any concerns you have.
- Learn as much as you can. Get in touch with others who have epilepsy. Keep up with news from epilepsy
organizations. Ask your healthcare professional to recommend groups and newsletters. Keep yourself
well-informed, and take an active role in your own care. And—if your healthcare professional decides
TOPAMAX is right for you—be sure to join Everyday Essentials™, the FREE support program for people
with epilepsy and their loved ones.
Define an Approach That Works for You
A healthy life is the goal: independence, with your seizures as controlled as possible and any limitations
overcome or kept to a minimum. But once you’ve set your goal, how do you get there?
The good news is, you’re not facing epilepsy alone. You can partner with your physician to find
the appropriate therapy and, if you’re taking medicine, the right dosage levels to control your seizures.
Be as active in your own care as you possibly can; if you experience side effects, get your healthcare
professional’s advice on how to counter or minimize them.
Treatment aside, you know your situation best. How you choose to deal with the challenges you face
depends not only on your condition, but also on who you are. How you choose to set up your life can
make the difference between merely coping and taking control.
Keep Learning
More than 2.7 million Americans have some form of epilepsy, and most of them live their lives with their condition, not around it. Get in touch with other people who are living with epilepsy, and learn what
has worked for them. Online communities and local organizations are a good place to start.
If you have questions about TOPAMAX, now there’s a way you can get answers quickly and easily from people who care.
Just call 1-877-YES-YOU-CAN to speak with friendly, knowledgeable healthcare professionals.
M-F, 9 AM to 5 PM EST
For more facts and information about epilepsy and its treatment, ask your healthcare professional
to recommend publications. Many responsible organizations devoted to epilepsy have Web sites, newsletters,
and other useful publications.
Make use of online resources. To read up on specific topics and concerns, visit the Epilepsy Foundation
Web site at www.epilepsyfoundation.org.
For links to many other epilepsy resources, visit the Epilepsy Information
Page of the National
Institutes of Health’s National Institute of Neurological Disorders and Stroke (NINDS). Please see
our Important Organizations and Resources page for more.
About TOPAMAX
TOPAMAX is approved as initial monotherapy in patients 10 years of age and older with partial-onset
or primary generalized tonic-clonic seizures.
Effectiveness was demonstrated in a controlled trial in patients with epilepsy who had no more
than 2 seizures in the 3 months prior to enrollment. Safety and effectiveness in patients
who were converted to monotherapy from a previous regimen of other anticonvulsant drugs have not
been established in controlled trials.
TOPAMAX is approved as add-on therapy for patients 2 years of age and older with primary generalized
tonic-clonic seizures, partial-onset seizures, or seizures associated with Lennox-Gastaut syndrome.
Important Safety Information
Serious risks associated with TOPAMAX include lowered bicarbonate levels in the blood resulting in an
increase in the acidity of the blood (metabolic acidosis). Symptoms could include hyperventilation
(rapid, deep breathing), tiredness, loss of appetite, irregular heartbeat or changes in the level of alertness.
Call your doctor immediately if you get these symptoms. Your doctor may want to do simple blood tests. Chronic,
untreated metabolic acidosis may increase the risk for kidney stones or bone disease.
Other serious risks include decreased sweating, increased body temperature, kidney stones, sleepiness,
dizziness, confusion, difficulty concentrating, and increased eye pressure (glaucoma). Call your doctor
immediately if you have any decrease in vision or eye pain. These problems can lead to blindness if not
treated right away.
More common side effects in adults are nervousness, coordination problems, fatigue, speech problems, slowed
thinking, memory difficulty, tingling in arms and legs, and double vision; and in children, fatigue, loss of appetite,
nervousness, memory difficulty, aggressive behavior, and weight loss.
As monotherapy, the most common side effects of TOPAMAX (in the 400 mg/day group and at a rate higher than the 50
mg/day group) in adults were tingling in arms and legs, weight decrease, sleepiness, loss of appetite, dizziness, and
difficulty with memory; and in children, weight decrease, upper respiratory tract infection, tingling in arms and legs,
loss of appetite, diarrhea, and mood problems.
In combination with other antiepileptic drugs (AEDs), the most common side effects of TOPAMAX in adults (200 to 400 mg/day)
were sleepiness, dizziness, nervousness, loss of muscle coordination, fatigue, speech disorders and related problems, psychomotor
slowing, abnormal vision, difficulty with memory, tingling in arms and legs, and double vision; and in children (5 to 9 mg/kg/day), fatigue,
sleepiness, loss of appetite, nervousness, difficulty with concentration/attention, difficulty with memory, aggressive reaction, and weight decrease.
Tell your doctor about other medications you take.
Please see full U.S. Prescribing Information.
© Ortho-McNeil Neurologics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. 1999-2009. All rights reserved.
Your use of the information on this site is subject to the terms of our Legal Statement. Please see our Privacy Policy.
This site is published by Ortho-McNeil Neurologics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., which is solely responsible for its contents.
Capitalized product names are trademarks of Ortho-McNeil Neurologics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
This information is intended for use by our customers, patients and healthcare professionals in the United States only. Ortho-McNeil Neurologics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. recognizes that the Internet is a global communications medium; however, laws, regulatory requirements and medical practices for pharmaceutical products vary from country to country. The prescribing information included here may not be appropriate for use outside the United States.
This site was last modified on: Jul 26 2007 at 13:45:31 EDT